Vascular Malformations
📧 Sign up to get email alerts when something new happens for Vascular Malformations.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS clinical trial (NCT05563831) has completed, providing an update on patients with PIK3CA-related overgrowth spectrum and related con…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias [Phase 3]
Phase 3 trial investigating octreotide for reducing blood and iron requirements in anemia due to angiodysplasias; study completed.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care [Phase 3]
Phase 3 clinical trial investigating efficacy and safety of sirolimus for vascular malformations refractory to standard care.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life [Phase 3]
Phase 3 trial update examining sirolimus for congenital vascular malformations to improve quality of life.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Electrosclerotherapy for Capillary Malformations [Phase 2]
Phase 2 clinical trial update examining electrosclerotherapy for capillary malformations and vascular malformations; status is UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of an mTOR inhibitor for vascular malformations has completed.